Endocyte Inc., of West Lafayette Ind., provided an update regarding the review of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) on the pending European Union conditional marketing authorization applications for vintafolide, etarfolatide and intravenous folic acid.